255
Views
30
CrossRef citations to date
0
Altmetric
Review

Safety and efficacy of pediculicides for head lice

&
Pages 169-179 | Published online: 22 Dec 2005

Bibliography

  • MEINKING TL, BURKHART CG, BURKHART CN: Ectoparasitic diseases in dermatology: reassessment of scabies and pediculosis. In: Advances in Dermatology (Volume 15). James W (Ed.), Mosby, St. Louis (1999):67-108.
  • MEINKING T, BURKHART CG, BURKHART CN. Infestations. In: Dermatology. Bolognia JL, Jorizzo JL, Rapini RP, (Eds), Mosby, St. Louis (2003):1321-1332.
  • MEINKING TL, SERRANO L, HARD B et al.: Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch. Dermatol. (2002) 138:220-224.
  • HANSEN RC: Guidelines for the treatment of resistant pediculosis. Contemporary Pediatrics (Suppl.). Medical Economics, Montvale, NJ. (2000):4-10.
  • FRANKOWSKI BL, WEINER LB: Committee on School Health and the Committee on Infectious Diseases. American Academy of Pediatrics. Head lice. Pediatrics (2002) 220:638-643.
  • BURKHART CG: Dermatologist’s response to the American Academy of Pediatrics guidelines on head lice. J. Drugs Dermatol. (2005) 5:14-15.
  • BURKHART CN, BURKHART CG: Head lice: scientific assessment of the nit sheath with clinical ramifications and therapeutic options. J. Am. Acad. Dermatol. (2005) 53:129-133.
  • BURKHART CN: Nit sheath and bacterial symbiotes of the human head louse (Pediculus humanus capitis) [Master’s Thesis]. Toledo, OH: Medical College of Ohio (2003).
  • BURKHART CN, STANKIEWICZ BA, PCHALEK I, BURKHART CG: Molecular composition of the louse sheath. J. Parasitol. (1999) 85:559-561.
  • BURKHART CN: Fomite transmission with head lice: a continuing controversy. Lancet (2003) 361:99-100.
  • BACOT AW: A contribution of the bionomics of Pediculus humanus and Pediculus capitis. Parasitology (1915) 9:228-258.
  • BURGESS IF: Human lice and their management. Adv. Parasitol. (1995) 36:271-342.
  • MAUDER JW: An update on head lice. Health Visitor (1993) 66:317-318.
  • BURKHART CN, BURKHART CG: Odds and ends of head lice: Characteristics, risk of fomite transmission, and treatment. J. Clin. Dermatol. (1999) 2:15-18.
  • TAKANO-LEE M, EDMAN JD, MULLENS BA, CLARK JM: Transmission potential of the human head louse, Pediculus capitis (Anoplura: Pediculidae). Int. J. Dermatol. (2005) 44:811-816.
  • SPEARE R, CAHILL C, THOMAS G: Head lice on pillows, and strategies to make a small risk even less. Int. J. Dermatol. (2003) 42:626-629.
  • BURKHART CN, BURKHART CG: Lice: The spectrum of disease in animal and man with special emphasis on whether head lice are possible vectors for systemic infections. J. Clin. Dermatol. (1998) 1(3):10-14.
  • FOURNIER A: Human pathogens in body and head lice. Emerging Infect. Dis. (2002) 8:1515-1518.
  • ROBINSON B: Potential role of head lice, Pediculus humanus capitis, as vectors of Rickettsia prowazekii. Parasitol. Res. (2003) 90:209-211.
  • NARAHASHI T: Neuronal ion channels as the target sites of insecticides. Pharmacol. Toxicol. (1996) 79:1-14.
  • SATTELLE DB, YAMAMOTOT D: Molecular targets of pyrethroid insecticides. In: Advances in Insect Physiology. Evans PD, Wigglesworth VB (Eds.) Academic Press, London (1988):147-213.
  • ADAMS ME, MILLER TA: Site of action of pyrethroids: repetitive ‘backfiring’ in flight motor units of house fly. Pestic. Biochem. Physiol. (1979) 11:218-231.
  • ADAMS ME, MILLER TA: Neural and behavioral correlates of pyrethroid and DDT type poisoning in the house fly Musca domestica. Pestic. Biochem. Physiol. (1980) 13:137-147.
  • WORLD HEALTH ORGANIZATION: Instructions for determining the susceptibility or resistance of body lice and head lice to insecticides. WHO/VBC (1981) 81:808.
  • POLLACK RJ, KISZEWSKI A, ARMSTRONG P: Differential permethrin susceptibility of head lice sampled in the United States and Borneo. Arch. Pediatr. Adolesc. Med. (1999) 153:969-973.
  • BURKHART CG, BURKHART CN: Clinical evidence of lice resistance to over-the-counter products. J. Cutan. Med. Surg. (2000) 4:199-201.
  • BURKHART CN, BURKHART CG: Recommendation to standardize pediculicidal and ovicidal testing for head lice (Anoplura: Pediculidae). J. Med. Entomol. (2001) 38:127-129.
  • DODD CS: Interventions for treating head lice. Cochrane Database Syst. Rev. (2001) 2:CD001165.
  • BURKHART CN, BURKHART CG: Topical pyrethroids: assessment of function and efficacy in head lice. Int. J. Pediatr. (2002) 17:209-212.
  • RUIGT GR: Pyrethroids. In: Comprehensive insect physiology biochemistry and pharmacology. Kerkut GA, Gilbert LI (EDS) Pergamon Press, Oxford (1988):183-263.
  • LIU N, SCOTT JG: Inheritance of CYP6D1-mediated pyrethroid resistance in house fly (Diptera: Muscidae). J. Econ. Entomol. (1997) 90:1478-1481.
  • FARNHAM AW: Genetics of resistance of houseflies (Musca domestica) to pyrethroids. I. Knock-down resistance. Pestic. Sci. (1977) 8:631-636.
  • MEINKING TL: Infestations. In: Current problems in dermatology, vol 11. Callen JP (Ed), Mosby, St. Louis, MO (1999):78-118.
  • TAKANO-LEE M, YOON KS, EMDAN JD, MULLENS BA, CLARK JM: In vivo and in vitro rearing of Pediculus humanus capitis (Anoplura: Pediculidae). J. Med. Entomol. (2003) 40:628-635.
  • MEINKING TL, TAPLIN D, KALTER DC, EBERLE MW: Comparative efficacy of treatments for pediculosis capitis infestations. Arch. Dermatol. (1986) 122:267-271.
  • BURKHART CG, BURKHART CN: An assessment of topical and oral prescription and over-the-counter treatment for head lice. J. Am. Acad. Dermatol. (1998) 38:979-982.
  • ELLIOTT M: Synthetic pyrethroids. In: Synthetic Pyrethroids. Elliott M (Ed.), ACS Symposium Series No. 42, American Chemical Society; Washington, D.C. (1977):1-28.
  • MEIKING TL, ENTZEL P, VILLAR ME: Comparative efficacy of treatments for pediculosis capitis infestations: update 2000. Arch. Dermatol. (2001) 137:287-292.
  • BURGESS IF, BROWN CM, PECK S: Head lice resistant to pyrethroid insecticides in Britain. Br. Med. J. (1995) 311:752.
  • DOWNS AMR, STAFFORD KA, COLES GC: Head lice: prevalence in school children and insecticide resistance. Parasitol. Today (1999) 15:1-5.
  • BAILEY AM, PROCIV P: Persistent head lice following multiple treatments: evidence for insecticide resistance in Pediculus humanus capitis. Australas. J. Dermatol. (2001) 42:146-149.
  • DOWNS AMR, STAFFORD KA, HUNT LP: Widespread insecticide resistance in head lice to the over-the-counter pediculicides in England and the emergence of carbaryl resistance. Br. J. Dermatol. (2002) 146:88-89.
  • JONES KN, ENGLISH JC: Review of common therapeutic options in the United States for the treatment of pediculosis capitis. Clin. Infect. Dis. (2003) 36:1355-1361.
  • O’MALLEY M: Clinical evaluation of pesticide exposure and poisonings. Lancet (1997) 349:1161-1166.
  • NARASHASHI T, GINSBURG KS, NAGATA K, SONG JH, TATEBAYASHI H: Ion channels as targets for insecticides. Neurotoxicology (1998) 19:581-590.
  • MUMCUOGLU KY, HEMINGWAY J, MILLER J: Permethrin resistance in the head louse Pediculus capitis from Israel. Med. Vet. Entomol. (1995) 9:427-432.
  • RUPES V, MORAVEK J SHMELA J: A resistance of head lice, Pediculus capitis, to permethrin in the Czech Republic. Cent. Eur. J. Pub. Hlth. (1995) 3:30-32.
  • VINUELAS J: Pediculosis resistente a permetrina. Enferm. Infec. Microbiol. Clin. (2001) 19:236-237.
  • ANDREWS EB, JOSEPH MC, MAGENHEIM MJ, TILSON HH, DOI PA, SCHULTZ MW: Postmarketing surveillance study of permethrin creme rinse. Am. J. Public Health (1992) 82:857-861.
  • BOWERMAN JG, GOMEZ MP, AUSTIN RD: Comparative study of permethrin 1% crème rinse and lindane shampoo for the treatment of head lice. Pediatr. Infect. Dis. (1987) 6:252-255.
  • CHOSIDOW O, CHASTANG C, BRUE C: Controlled study of malathion and d-phenothrin lotions for Pediculus humnaus var capitis-infested school children. Lancet (1994) 344:1724-1727.
  • DOWNS AMR, STAFFORD KA, COLES GC: Monoterpenoides and tetralin as pediculocides. Acta. Dermatol. Venereol. (1999) 79:1-2.
  • MEINKING TL, SERRANO L, HARD B: Comparative in vitro pediculocidal efficacy of treatments in a resistant head lice population. Arch. Dermatol. (2002) 138:220-224.
  • HA YC, HEO JM, KIM HJ: Infestation status of head louse and treatment with lindane shampoo in children of primary school and kindergarten in Chinju-shi, Kyongsangnamdo, Korea. Korean J. Parasitol. (2000) 38:41-43.
  • CALIFORNIA DEPARTMENT OF HEALTH SERVICES: State health director offers tips for protecting children from head lice. Sacramento: California Dept of Health Services; October 10, 2000. News Release No. 54-00.
  • DOWNS AMR: Managing head lice in an era of increasing resistance to insecticides. Am. J. Clin. Dermatol. (2004) 5:169-177.
  • MEINKING TL, VICARIA M EYERDAM DH, VILLAR ME, REYNA S, SUAREZ G: Efficacy of a reduced application time of Ovid lotion (0.5% malathion) compared to Nix crème rinse (1% permethrin) for the treatment of head lice. Ped. Dermatol. (2004) 21:670-674.
  • BURKHART CN, BURKHART CG: Head lice revisited: in vitro standardized tests and differences in malathion formulations. Arch. Dermatol. (2004) 140:488-489.
  • TAPLIN D, CASTILLERO PM, SPIEGEL J: Malathion for treatment of Pediculus humanus var capitis infestation. JAMA (1982) 247:3103-3105.
  • DOWNS AMR, STAFFORD KA, HARVEY E: Evidence for double resistance to permethrin and malathion in head lice. Br. J. Dermatol. (1999) 141:508-1511.
  • ROBERTS RJ, CASEY D, MORGAN DA: Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomized controlled trial. Lancet (2000) 356:540-544.
  • KYLE DR: Comparison of phenothrin shampoo and malathion lotion in the treatment of head louse infection. J. R Soc. Hlth. (1990) 110:62-63.
  • BLASIAK J, JALOSZYNSKI P, TRZECIAK A, SZYFTER K: In vitro studies on the genotoxicity of the organophosphorus insecticide malathion and its two analogues. Mutat. Res. (1999) 445:275-283.
  • DENNIS GA, LEE PN: A Phase I volunteer study to establish the degree of absorption and effect on cholinesterase activity of four head lice preparations containing malathion. Clin. Drug Invest. (1999) 18:105-115.
  • CAMPBELL WC: Ivermectin and Abamectin. Springer-Verlag, New York (1989):149-161, 215-229.
  • PARADIS M, DE JAHAM C, PAGE N: Topical (pour-on) ivermectin in the treatment of canine scabies. Can. Vet. J. (1997) 38:379-382.
  • BURKHART CN: Ivermectin: an assessment of its pharmacology, microbiology, and safety. Vet. Human Toxicol. (2000) 42:30-35.
  • YOUSSEF MY, SADAKA HA, EISSA MM, EL-ARINY AF: Topical application of ivermectin for human ectoparasites. Am. J. Trop. Med. Hyg. (1995) 53:652-653.
  • GLAZIOU P, NYGUYEN LN, MOULIA-PELAT JP, CARTEL JL, MARTIN PM: Efficacy of ivermectin for the treatment of head lice (Pediculosis capitis). Trop. Med. Parasitol. (1994) 45:253-254.
  • VICTORIA J, TRUJILLO R: Topical ivermectin: a new successful treatment for scabies. Pediatr. Dermatol. (2001) 18:63-65.
  • MUMCUOGLU KY, MILLER J, ZAMIR C, ZENTNER C, HELBIN V, INGBER A: The in vivo pediculicidal efficacy of a natural remedy. Isr. Med. Assoc. J. (2002) 4:790-793.
  • NAKAMURA T, OKUYAMA E, YAMAZAKI M: Neurotropic components from star anise (Illicium verum Hook. fil.). Chem. Pharm. Bull. (1996) 44:1908-1914.
  • GARZO FC, GOMEZ PP, BLANCO PP: Cases of neurological symptoms associated with star anise consumption used as a carminative. Anales Espanoles de Pediatria. (2002) 57:290-294.
  • KAKEMOTO E, OKUYAMA E, NAGATA K, OZOE Y: Interaction of anisatin with rat brain gamma-aminobutyric acidA receptors: allosteric modulation by competitive antagonists. Biochem. Pharmacol. (1999) 58:617-621.
  • PLASTOW L, LUTHRA M, POWELL R, WRIGHT J, RUSSELL D, MARSHALL MN: Head lice infestation: bug busting versus traditional treatment. J. Clin. Nursing (2001) 42:775-783.
  • BURKHART CN, BURKHART CG, PCHALEK I, AROGAST J: The adherent cylindrical nit structure and its chemical denaturation in vitro: an assessment with therapeutic implication for head lice. Arch. Pediatr. Adoles. Med. (1998) 1152:711-712.
  • SIM S, LEE IY, LEE KY: A survey on head lice infestation in Korea (2001) and the therapeutic efficacy of oral trimethoprim/sulfamethoxazole adding to lindane shampoo. Korean J. Parasitol. (2003) 41:57-61.
  • HIPOLITO RB, MALLORCA FG, ZUNIGA-MACARAIG ZO, APOLINARIO PC, WHELLER-SHERMAN J: Head lice infestation: single drug versus combination therapy with one percent permethrin and trimethoprim/sulfamethoxazole. Pediatrics (2001) 107:E30.
  • MORSY TA, RAMADAN NI, MAHMOUD MS, LASHEN AH: On the efficacy of Co-trimoxazole as an oral treatment for pediculosis capitis infestation. J. Egypt Soc. Parasitol. (1996) 26:73-77.
  • PEARLMAN DL: A simple treatment for head lice: dry-on, suffocation-based pediculicide. Pediatrics (2004) 114:e275-e279.
  • BURGESS IF, BROWN CM, LEE PN: Treatment of head louse infestation with 4% dimeticone lotion: randomized controlled equivalence trial. Br. Med. J. (2005) 220:1423-1425.

Website

  • http://www.fda.gov/cder/drug/infopage/lindane/default.htm FDA Public Health Advisory: Safety of topical lindane products for the treatment of scabies and lice. Center for Drug Evaluation and Research (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.